Future Care for Medical Industries (FCMI) results, Q2 2023
Net profit, assets, equity and cash flow for Q2 2023, against the same period a year earlier, from the published financial statements.
Net profit247 thousandEGP · +753.4% vs the same period a year earlier
Total assets76.18 millionEGP · +21.5% vs the same period a year earlier
Shareholders' equity58.2 millionEGP · −2.4% vs the same period a year earlier
Operating cash flow16.34 millionEGP · +802.4% vs the same period a year earlier
In short
- Future Care for Medical Industries (FCMI)'s net profit for Q2 2023 was about 247 thousand EGP, up +753.4% from -37.81 thousand EGP in Q2 2022.
- Total assets at the end of Q2 2023 were about 76.18 million EGP, and shareholders' equity about 58.2 million EGP.
- Operating cash flow for Q2 2023 was positive at 16.34 million EGP.
Key lines against the same period a year earlier
This periodQ2 2022Change
Net profit247 thousand-37.81 thousand+753.4%
Gross profit-23.93 thousand141 thousand−117.0%
Total assets76.18 million62.72 million+21.5%
Total liabilities17.98 million3.08 million+483.9%
Shareholders' equity58.2 million59.64 million−2.4%
Total liabilities and equity76.18 million62.72 million+21.5%
Operating cash flow16.34 million-2.33 million+802.4%
Investing cash flow-1 million-821 thousand−21.7%
Financing cash flow-16.14 million-453 thousand−3459.9%
Net change in cash-801 thousand-3.6 million+77.8%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
Future Care for Medical Industries (FCMI)'s Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy